what is the peptide name for tirzepatide 10mg — GLP-1/GIP Dual-Agonist Research Tirzepatide (GLP-1/GIP) - 15mg -

Standard titration protocol from clinical trials The Phase 2 NEJM trial used the following escalation schedule for the 12 mg dose group: Weeks 1 through 4: 2 mg once weekly (subcutaneous) Weeks 5 through 8: 4 mg once weekly Weeks 9 through 12: 8 mg once weekly Week 13 and beyond: 12 mg once weekly (maintenance dose) For the 8 mg target dose, the schedule was: Weeks 1 through 4: 2 mg once weekly Weeks 5 through 8: 4 mg once weekly Week 9 and beyond: 8 mg once weekly (maintenance dose) These titration schedules are not suggestions

These are distinct from injection site reactions because they can appear anywhere on the body

That can also lead to dehydration"

Analysis was carried out in terms of fold change in lipid peroxidation level